BioSpace News Archive

Business

OpenBench and Tavros Therapeutics Announce Collaboration to Pursue First-in-class Cancer Target

Tavros Therapeutics, and OpenBench, today announced a collaboration in which OpenBench will identify novel, potent antagonists against an undisclosed cancer target that was identified by Tavros’s proprietary functional genomics platform.

December 2, 2021
·
2 min read
Bonus BioGroup Reports 94% Survival Rate for Severe COVID-19 Cases in the Phase II Clinical Trial of its MesenCure Treatment

The positive results reported by the Company coincide with the emergence of the highly-mutated Omicron variant that has regalvanized the international community’s commitment to developing long-term solutions for the ongoing pandemic.

December 2, 2021
·
6 min read
Business

Fore Biotherapeutics Issues Statement

Fore Biotherapeutics, a precision oncology company focused on providing people with unaddressed cancer mutations new hope by connecting them with hyper-targeted medicines using its proprietary functional genomics platform, issued the following statement.

December 2, 2021
·
2 min read
Near Infrared Spectroscopy Market Size to Reach Valuation of USD 437.3 Million in 2028 Growing at a CAGR of 6.2%, according to Emergen Research

The global near infrared spectroscopy market size is expected to reach USD 437.3 Million at a steady CAGR of 6.2% in 2028, according to latest analysis by Emergen Research.

December 2, 2021
·
6 min read
Nerve Repair and Regeneration Market Size to Reach Valuation of USD 11.62 Billion by 2027 Growing at a CAGR of 9.0%, according to Emergen Research

The global Nerve Repair and Regeneration Market size will be worth USD 11.62 Billion by 2027, according to a current analysis by Emergen Research.

December 2, 2021
·
5 min read
Cancer Pain Market Size to Reach USD 8.51 Billion in 2028 With CAGR of 4.3%, Says Reports and Data

Growing awareness of cancer pain as a global clinical problem, increasing focus on developing comprehensive approach to classify cancer pain, and extensive R&D activities to develop advanced non-invasive pain management techniques are some key factors expected to drive market growth.

December 2, 2021
·
6 min read
Stem Cells Market Size to Reach USD 19.31 Billion in 2028 With CAGR of 8.4%, Says Reports and Data

Growing developments in regenerative medicine, increasing investment by pharmaceutical and biotechnology companies to develop cell-based therapeutics, and advancements in tissue engineering techniques are some key factors expected to drive market growth.

December 2, 2021
·
7 min read
Biotech Beach

Ionis to hold virtual investor day event

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a virtual investor day on Thursday, December 9th at 11:00 a.m. Eastern Time.

December 2, 2021
·
1 min read
BioForest

CTI BioPharma to Present at the JMP Securities Hematology & Oncology Summit on Monday, December 6

CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the JMP Securities Hematology & Oncology Summit at 3:40 p.m. ET.

December 2, 2021
·
1 min read
Policy

Ascletis Announces Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/ GANOVO® Regimen, an All-oral Direct Anti-HCV Therapy

Ascletis Pharma Inc. announces that its all-oral direct anti-hepatitis C virus ASCLEVIR® / GANOVO® regimen has been included in the Medicine Catalog for National Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance .

December 2, 2021
·
4 min read